The Biden-Harris administration proposed a new rule Tuesday to cover the cost of weight-loss drugs like Ozempic, Wegovy and Mounjaro for millions of Americans.
The Department of Health and Human Services (HHS) initiative would apply to Medicare and Medicaid enrollees with body mass indexes of 30 or higher, and would cost U.S. taxpayers as much as $35 billion over the next decade, according to The Associated Press.
Read the full story